Affordable Genome Sequencing for Pathogen Analysis to Address Epidemics
As genomic surveillance of COVID-19 continues, the ability of countries to contribute through rapid whole genome sequencing has become more important.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Anatomic Pathology, Covid 19 |
As genomic surveillance of COVID-19 continues, the ability of countries to contribute through rapid whole genome sequencing has become more important.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Covid 19 |
Researchers are developing a novel approach of SARS-CoV-2 testing based on quantum effects that may lead to more efficient test methods.
Read MorePosted by Andy Lundin | Dec 22, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Global medical technology company BD has completed the acquisition of privately held Scanwell Health, a provider in smartphone-enabled at-home medical tests.
Read MorePosted by Chris Wolski | Dec 21, 2021 | Covid 19, POC Rapid Assays |
President Joe Biden outlined a new plan to combat the surging Omicron variant, including a plan to deploy millions of at-home tests.
Read MorePosted by Andy Lundin | Dec 21, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus.
Read More